Business Description
Compare
Compare
Traded in other countries / regions
IPO Date
2015-12-22Description
Rex Bionics PLC, formerly known as Union MedTech PLC, was incorporated and domiciled in england and Wales on February 27, 2012. The Company is engaged in the research & development, manufacturing and commercialisation of robotic devices designed to provide physiotherapy to and improve the physical and psychological well-being of people with mobility impairment as a result of spinal cord injury or other neurological damage. It provides independent mobility to wheelchair users and other mobility impaired persons using robotic technology, custom-designed electromechanical actuators, precision engineering, and specialised networking systems.The Company's REX devices are REX Rehab and REX Personal.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | No Debt | |||||
| Equity-to-Asset | 0.87 | |||||
| Interest Coverage | No Debt | |||||
| Piotroski F-Score | 7/9 | |||||
| Altman Z-Score | 1.41 | |||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | -56 |
Momentum Rank
| Name | Current | Vs Industry | Vs History |
|---|
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.6 | |||||
| Quick Ratio | 1.6 | |||||
| Days Sales Outstanding | 49.25 | |||||
| Days Payable | 1095 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -7.7 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 99.21 | |||||
| Operating Margin % | -238.1 | |||||
| Net Margin % | -1830.16 | |||||
| ROE % | -246.28 | |||||
| ROA % | -194.52 | |||||
| ROIC % | -32.97 | |||||
| ROC (Joel Greenblatt) % | -467.58 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 2.86 | |||||
| PB Ratio | 0.91 | |||||
| Price-to-Operating-Cash-Flow | 6.67 | |||||
| EV-to-EBIT | -0.08 | |||||
| EV-to-EBITDA | -0.08 | |||||
| EV-to-Revenue | 1.43 | |||||
| Earnings Yield (Greenblatt) % | -1250 | |||||
| FCF Yield % | 13.11 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:RXRBY
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Rex Bionics PLC Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | -3.6 | ||
| Beta | 0 | ||
| Volatility % | 0 | ||
| 14-Day RSI | 0 | ||
| 14-Day ATR ($) | 0 | ||
| 20-Day SMA ($) | 0 | ||
| 12-1 Month Momentum % | 0 | ||
| 52-Week Range ($) | 0 - 0 | ||
| Shares Outstanding (Mil) | 2.55 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 7 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Rex Bionics PLC Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Rex Bionics PLC Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Rex Bionics PLC Frequently Asked Questions
What is Rex Bionics PLC(RXRBY)'s stock price today?
The current price of RXRBY is $0.00. The 52 week high of RXRBY is $0.00 and 52 week low is $0.00.
When is next earnings date of Rex Bionics PLC(RXRBY)?
The next earnings date of Rex Bionics PLC(RXRBY) is .
Does Rex Bionics PLC(RXRBY) pay dividends? If so, how much?
Rex Bionics PLC(RXRBY) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers